Nurse-Led BBTi for Post-stroke Insomnia
Launched by TAIPEI MEDICAL UNIVERSITY · May 2, 2021
Trial Information
Current as of June 01, 2025
Completed
Keywords
ClinConnect Summary
Post-stroke insomnia is a common complaint with prevalence rates remain high. Patients suffering from insomnia following stroke could impair their health-related quality of life and negative rehabilitation outcomes. Identifying effective treatment in managing post-stroke insomnia has become clinically relevant.
Brief behavioral therapy for insomnia (BBTI), a 4-section of treatment for insomnia, has similar treatment components with CBTI, with the exception of cognitive therapy. Previous evidence found that both BBTI and CBTI have comparable effects on improving sleep quality and consolidat...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Had diagnosed with stroke for at least 3 months (chronic phase)
- • Had NIHSS score \< 6
- • Complain insomnia symptom based on the score of ISI\> 7
- • Having sufficient cognitive function to complete tasks,
- • Able to access to internet
- Exclusion Criteria:
- • The people receiving BBTI and other psychological treatment for insomnia
- • Doing shift work
- • Having psychiatric disorders
- • Being pregnant or breastfeeding
- • Having other sleep disorders (e.g., sleep apnea)
- • Drugs or alcohol abuse,
- • Serious or unstable medical condition prior to the study
About Taipei Medical University
Taipei Medical University (TMU) is a leading educational and research institution located in Taipei, Taiwan, dedicated to advancing health sciences and clinical research. Established with a focus on fostering innovation in medical education, TMU integrates comprehensive clinical training with rigorous research methodologies. The university is committed to improving patient outcomes through a strong emphasis on translational medicine and interdisciplinary collaboration. TMU's clinical trial initiatives are designed to explore new treatments and therapies, contributing to the global body of medical knowledge while adhering to the highest ethical standards and regulatory compliance.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Trial Officials
Hsiao-Yean Chiu, Ph.D.
Principal Investigator
Taipei Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials